Evidence map›Paper›PMID 34504080›Full record

ArticleNature communications2021

Accelerated functional brain aging in pre-clinical familial Alzheimer's disease.

Julie Gonneaud, Alex T Baria, Alexa Pichet Binette, Brian A Gordon, Jasmeer P Chhatwal, Carlos Cruchaga, Mathias Jucker, Johannes Levin, Stephen Salloway, Martin Farlow and 11 more

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 2 pooled it
7.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 2 syntheses or guidelines pooled it, 96 citations in OpenAlex.

  1. Pooled it
  2. The application value of Rs-fMRI-based machine learning models for differentiating mild cognitive impairment from Alzheimer's disease: a systematic review and meta-analysis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2025
    Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Human Brain Cell-Type-Specific Aging Clocks Based on Single-Nuclei Transcriptomics.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  13. Article
  14. When Age Is More Than a Number: Acceleration of Brain Aging in Neurodegenerative Diseases.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors at 20 institutions in 8 countries.

Julie GonneaudDouglas Mental Health University Institute, McGill University, Montreal, QC, Canada. julie.gonneaud@mail.mcgill.ca.ORCID 0000-0003-0566-5581
Alex T BariaDouglas Mental Health University Institute, McGill University, Montreal, QC, Canada.
Alexa Pichet BinetteDouglas Mental Health University Institute, McGill University, Montreal, QC, Canada.ORCID 0000-0001-5218-3337
Brian A GordonKnight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0003-2109-2955
Jasmeer P ChhatwalBrigham and Women's Hospital-Massachusetts General Hospital, Boston, MA, USA.ORCID 0000-0002-7792-1698
Carlos CruchagaKnight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-0276-2899
Mathias JuckerHertie-Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany.ORCID 0000-0001-9045-1072
Johannes LevinLudwig-Maximilians-Universität München, German Center for Neurodegenerative Diseases and Munich Cluster for Systems Neurology (SyNergy), Munich, Germany.ORCID 0000-0001-5092-4306
Stephen SallowayButler Hospital, Providence, RI, USA.ORCID 0000-0002-2631-0942
Martin FarlowDepartment of Neurology, Indiana University School of Medicine, Indianapolis, IN, USA.
Serge GauthierDouglas Mental Health University Institute, McGill University, Montreal, QC, Canada.
Tammie L S BenzingerKnight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-8114-0552
John C MorrisKnight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.
Randall J BatemanKnight Alzheimer Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA.ORCID 0000-0002-7729-1702
John C S BreitnerDouglas Mental Health University Institute, McGill University, Montreal, QC, Canada.
Judes PoirierDouglas Mental Health University Institute, McGill University, Montreal, QC, Canada.ORCID 0000-0002-8018-4545
Etienne Vachon-Presseau *Department of Anesthesia, Faculty of Medicine, McGill University, Montreal, QC, Canada.ORCID 0000-0002-8681-3154
Sylvia Villeneuve *Douglas Mental Health University Institute, McGill University, Montreal, QC, Canada. sylvia.villeneuve@mcgill.ca.ORCID 0000-0003-2338-0467
Alzheimer’s Disease Neuroimaging Initiative (ADNI)
Dominantly Inherited Alzheimer Network (DIAN) Study Group
Pre-symptomatic Evaluation of Experimental or Novel Treatments for Alzheimer’s Disease (PREVENT-AD) Research Group
Douglas Mental Health University Institute · CAMayo Clinic in Florida · USIndiana University Bloomington · USBrigham and Women's Hospital · USProvidence College · USWashington University in St. Louis · USMontreal Neurological Institute and Hospital · CANew York University · USThe University of Texas Southwestern Medical Center · USUC San Diego Health System · USUniversity of California, Irvine · USUniversity of Pennsylvania · USUniversity of Pittsburgh · USUniversity of Southern California · USWinnMed · USUniversity of Alabama at Birmingham · USUniversity of California, Davis · USUniversity of California, Los Angeles · USUniversity of Kentucky · USUniversity of Rochester Medical Center · US

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
National Centralized Repository for Alzheimer's Disease and Related Dementias (NCRAD)U24AG021886 · NIA · INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS · PI TATIANA M. FOROUD · 2002 to 2026
$119.8M
Imaging CoreU19AG032438 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2010 to 2025
$53.9M
Research Education CoreP30AG066462 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI Andrew Franklin Teich · 2020 to 2026
$30.1M
Dominantly Inherited Alzheimer NetworkUF1AG032438 · NIA · WASHINGTON UNIVERSITY · PI BATEMAN, RANDALL J · 2014 to 2017
$21.6M
Multicultural Community Dementia ScreeningR01AG071514 · NIA · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI GALVIN, JAMES E · 2021 to 2025
$13.8M
Stanford Medicine Center for Longevity and Healthy Aging Research Education CoreP30AG059307 · NIA · STANFORD UNIVERSITY · PI ZOU, JAMES · 2018 to 2025
$4.9M
PURCHASE OF A SIEMENS NEXT GENERATION PET/CTS10OD025214 · OD · WASHINGTON UNIVERSITY · PI WOODARD, PAMELA K · 2018 to 2018
$2.0M
NIA NIH HHS P30 AG059307NIA NIH HHS P30 AG066462NIA NIH HHS R01 AG071514NIA NIH HHS U01 AG024904NIA NIH HHS U19 AG032438NIA NIH HHS U24 AG021886NIA NIH HHS UF1 AG032438NIH HHS S10 OD025214
6 · The paper itself

Abstract

Resting state functional connectivity (rs-fMRI) is impaired early in persons who subsequently develop Alzheimer's disease (AD) dementia. This impairment may be leveraged to aid investigation of the pre-clinical phase of AD. We developed a model that predicts brain age from resting state (rs)-fMRI data, and assessed whether genetic determinants of AD, as well as beta-amyloid (Aβ) pathology, can accelerate brain aging. Using data from 1340 cognitively unimpaired participants between 18-94 years of age from multiple sites, we showed that topological properties of graphs constructed from rs-fMRI can predict chronological age across the lifespan. Application of our predictive model to the context of pre-clinical AD revealed that the pre-symptomatic phase of autosomal dominant AD includes acceleration of functional brain aging. This association was stronger in individuals having significant Aβ pathology.

Indexed as

AgingAdultAgedAged, 80 and overAlzheimer DiseaseAmyloid beta-PeptidesBrainBrain MappingCognitive DysfunctionFemaleGenetic Predisposition to DiseaseHumansLongitudinal StudiesMagnetic Resonance ImagingMaleMiddle AgedAmyloid beta-Peptides

Identifiers

PMID34504080
PMCPMC8429427
OpenAlexW3198174135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.